{"title":"Harmony™ Valve Implantation in the Right Pulmonary Artery in a Patient with Repaired Tetralogy of Fallot and Left Pulmonary Artery Occlusion: A Case Report","authors":"Masaru Yabusaki MD, Saki Hasegawa MD, Shintaro Nakano MD, Takuro Kojima MD, PhD","doi":"10.1016/j.jccase.2026.07.017","DOIUrl":"10.1016/j.jccase.2026.07.017","url":null,"abstract":"<div><div>Transcatheter pulmonary valve implantation using the Harmony™ valve (Medtronic, Minneapolis, MN, USA) has expanded treatment options for pulmonary regurgitation in patients with enlarged right ventricular outflow tracts. However, complex pulmonary artery anatomy may preclude standard implantation in the main pulmonary artery. We report a 41-year-old woman with repaired tetralogy of Fallot and complete left pulmonary artery occlusion who developed severe pulmonary regurgitation and advanced biventricular dysfunction. Implantation in the main pulmonary artery was not feasible because of unfavorable anatomy and a significant pressure gradient. A 25-mm Harmony™ valve was therefore successfully implanted in the proximal right pulmonary artery, preserving branch perfusion and without creating additional pressure gradients. The patient's clinical condition stabilized without procedural complications. This case suggests that right pulmonary artery implantation of the Harmony™ valve may be a viable alternative in carefully selected patients with unilateral pulmonary artery occlusion when standard implantation is not feasible.</div></div><div><h3>Learning objectives</h3><div>This case highlights that the Harmony™ valve can be implanted in the proximal right pulmonary artery when standard main pulmonary artery implantation is not feasible. In patients with complex pulmonary artery anatomy, careful anatomical and hemodynamic assessment may enable alternative implantation strategies that preserve branch perfusion without creating additional pressure gradients.</div></div>","PeriodicalId":52092,"journal":{"name":"Journal of Cardiology Cases","volume":"34 5","pages":"Pages 224-226"},"PeriodicalIF":0.0,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149314463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Simultaneous two-vessel occlusion causing ST-segment elevation myocardial infarction associated with elevated lipoprotein (a): A case report","authors":"Shingo Watanabe MD, Junichi Onuma MD, Ryota Ishida MD, Ryo Masuda MD, Michio Usui MD","doi":"10.1016/j.jccase.2026.07.002","DOIUrl":"10.1016/j.jccase.2026.07.002","url":null,"abstract":"<div><div>Simultaneous occlusion of two coronary arteries during ST-segment elevation myocardial infarction (STEMI) is rare and often associated with hemodynamic instability and poor prognosis. Identification of predisposing factors is crucial for prevention and risk stratification. A 53-year-old man with no classic cardiovascular risk factors other than smoking presented with inferoposterior STEMI complicated by syncope. Emergency coronary angiography revealed simultaneous occlusion of the proximal right coronary artery and distal left circumflex artery. Primary percutaneous coronary intervention was successfully performed in both vessels using intravascular imaging guidance. Subsequent evaluation demonstrated markedly elevated lipoprotein(a) levels (88 mg/dL) in the absence of other thrombotic or inflammatory disorders. Multimodality imaging revealed lipid-rich, macrophage-infiltrated plaques in multiple coronary arteries. Intensive lipid-lowering therapy achieved plaque stabilization during follow-up. This case suggests that elevated lipoprotein(a) may be associated with simultaneous multivessel coronary thrombosis and could contribute to plaque vulnerability and thrombogenicity, highlighting the importance of aggressive lipid management.</div></div><div><h3>Learning objective</h3><div>Simultaneous multivessel coronary occlusion is a rare but life-threatening presentation of ST-segment elevation myocardial infarction. This case illustrates that markedly elevated lipoprotein(a) may be associated with widespread plaque vulnerability, emphasizing the importance of considering lipoprotein(a) measurement and intensive lipid-lowering therapy even in patients without traditional cardiovascular risk factors.</div></div>","PeriodicalId":52092,"journal":{"name":"Journal of Cardiology Cases","volume":"34 5","pages":"Pages 215-218"},"PeriodicalIF":0.0,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149314465","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Feasibility of steerable sheath-guided left atrial appendage closure in challenging anatomy","authors":"Sho Shiba MD, Masanori Yamamoto MD, Tatsuya Tsunaki RT, Ryo Yamaguchi MD","doi":"10.1016/j.jccase.2026.07.014","DOIUrl":"10.1016/j.jccase.2026.07.014","url":null,"abstract":"<div><div>Percutaneous left atrial appendage closure (LAAC) is an established treatment option for stroke prevention in patients with non-valvular atrial fibrillation (NVAF) who are unsuitable for long-term oral anticoagulation. However, an anatomically challenging left atrial appendage (LAA) can limit optimal device positioning and complete occlusion with conventional fixed-curve sheaths.</div><div>Two elderly men with NVAF and high bleeding risk underwent LAAC using Watchman FLX Pro devices (Boston Scientific, Marlborough, MA, USA). Pre-procedural imaging revealed anatomically challenging LAAs. With a standard double-curve sheath, one case showed unacceptable posterior protrusion of a large 40-mm device. In another case, tilting of the device led to incomplete coverage of the posterior lobe, resulting in a residual peri-device leak. After switching to the TruSteer™ Access System (Boston Scientific), a bidirectional steerable sheath, improved coaxial alignment, enabled acceptable device protrusion, complete sealing with no residual leak, and stable device release in both cases. These cases suggest that a steerable sheath can overcome the limitations of fixed-curve sheaths in anatomically challenging LAAs by enabling coaxial alignment and optimized posterior wall apposition during LAAC.</div></div><div><h3>Learning objective</h3><div>In wide-neck, shallow, or multilobed left atrial appendages (LAAs), failure to meet PASS criteria with a conventional fixed-curve sheath may reflect non-coaxial deployment and, with very large devices, sheath instability due to kick-back at release, leading to device tilt. A bidirectional steerable sheath provides real-time control of the delivery axis and may prevent kick-back at release, enabling reproducible optimal device positioning in anatomically challenging LAAs where fixed-curve sheaths are inadequate.</div></div>","PeriodicalId":52092,"journal":{"name":"Journal of Cardiology Cases","volume":"34 5","pages":"Pages 191-194"},"PeriodicalIF":0.0,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149314824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Fondaparinux as an alternative anticoagulant in a pregnant woman with heparin-induced delayed-type hypersensitivity reaction","authors":"Kazumasa Kuwayama MD, Madoka Sano MD, Reina Tanaka MD, Kanon Morimoto MD, Takashi Nishikawa MD, Yutaka Furukawa MD, PhD, FJCC","doi":"10.1016/j.jccase.2026.07.005","DOIUrl":"10.1016/j.jccase.2026.07.005","url":null,"abstract":"<div><div>Heparin is commonly administered to prevent and treat venous thromboembolism during pregnancy. However, alternative anticoagulants should be considered in case of adverse reactions. Herein, we present a case of a heparin-induced delayed-type hypersensitivity reaction successfully managed with fondaparinux. The patient, a 40-year-old pregnant woman, developed acute pain and swelling in the left lower limb at 11 weeks of gestation; she was subsequently diagnosed with deep venous thrombosis. Anticoagulation therapy was initiated with intravenous unfractionated heparin (UFH), subsequently switched to subcutaneous UFH. However, three weeks following therapy initiation, she developed multiple pruritic erythematous plaques at the injection sites. An intradermal test for UFH was positive at 48 h, confirming a diagnosis of delayed-type hypersensitivity reaction. In subsequent testing, cross-reactivity was observed with low-molecular-weight heparin, but not with fondaparinux. The patient was successfully managed with subcutaneous fondaparinux and delivered without complications, with a reduction in thrombus size.</div><div>This case highlights that fondaparinux may serve as a safe and effective alternative anticoagulant for pregnant patients with heparin intolerance.</div></div><div><h3>Learning objective</h3><div>Pregnancy is associated with a hypercoagulable state and an increased risk of venous thromboembolism (VTE). Anticoagulant options are limited in pregnant women, and subcutaneous heparin is the first-line treatment for VTE during pregnancy. However, subcutaneous heparin is contraindicated in some cases due to allergic reactions, including delayed-type hypersensitivity reactions. Fondaparinux may be considered as an alternative anticoagulant for patients with heparin intolerance during pregnancy.</div></div>","PeriodicalId":52092,"journal":{"name":"Journal of Cardiology Cases","volume":"34 5","pages":"Pages 207-210"},"PeriodicalIF":0.0,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149314835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Ivabradine for inappropriate sinus node-mediated tachycardia associated with hemodynamic deterioration after acute myocardial infarction: A case report","authors":"Yui Koyanagi MD, Yuya Nakamura MD, PhD, Mamiko Yamada MD, Masashi Katagiri MD, Yosuke Oishi MD, PhD, Toshiro Shinke MD, PhD, FJCC","doi":"10.1016/j.jccase.2026.07.018","DOIUrl":"10.1016/j.jccase.2026.07.018","url":null,"abstract":"<div><div>Sinus tachycardia is common after acute myocardial infarction (AMI), but persistent tachycardia disproportionate to clinical status may worsen hemodynamics. We report a case of refractory sinus tachycardia associated with hemodynamic deterioration following AMI that responded to ivabradine. A 57-year-old woman developed cardiogenic shock due to anterior myocardial infarction and underwent emergency percutaneous coronary intervention with mechanical circulatory support. During recovery, she developed persistent sinus tachycardia exceeding 120 bpm, accompanied by worsening pulmonary congestion and increased pulmonary artery wedge pressure. Electrocardiography demonstrated sinus rhythm with gradual warm-up and cool-down patterns, without abrupt onset or termination, suggesting inappropriate sinus node–mediated tachycardia. Beta-blockers were avoided because of hypotension and ongoing inotropic support. Ivabradine was initiated, resulting in prompt heart rate reduction and improvement in hemodynamics, including decreased pulmonary artery wedge pressure and improved left ventricular filling. Dobutamine may have contributed to the tachycardia; however, the persistent and disproportionate nature of the sinus tachycardia suggested enhanced sinus node automaticity. This case highlights that inappropriate sinus node–mediated tachycardia may contribute to hemodynamic deterioration after AMI and that ivabradine can be an effective therapeutic option when beta-blockers are not tolerated.</div></div><div><h3>Learning objective</h3><div>Disproportionate sinus tachycardia can occur even during the acute phase of myocardial infarction and may worsen hemodynamic status. When sinus tachycardia persists despite correction of reversible causes and appears excessive relative to the clinical condition, inappropriate sinus node-mediated tachycardia should be considered. Ivabradine may be an effective therapeutic option when beta-blockers are not suitable.</div></div>","PeriodicalId":52092,"journal":{"name":"Journal of Cardiology Cases","volume":"34 5","pages":"Pages 235-238"},"PeriodicalIF":0.0,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149314470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Internal jugular vein approach facilitating second leadless pacemaker implantation after battery depletion","authors":"Nobuhiko Ueda MD, PhD, Kohei Ishibashi MD, PhD, Akinori Wakamiya MD, PhD, Mitsuru Wada MD, PhD, Kengo Kusano MD, PhD","doi":"10.1016/j.jccase.2026.07.006","DOIUrl":"10.1016/j.jccase.2026.07.006","url":null,"abstract":"<div><div>Leadless pacemakers (LLPMs) have become an established treatment for bradyarrhythmias because they are associated with fewer lead-related complications and infections than transvenous pacemakers. However, when battery depletion occurs, implantation of a second device may be technically more challenging than the initial procedure because the available right ventricular (RV) implantation sites are limited by the existing device. We report a case of second LLPM implantation using the internal jugular vein (IJV) approach. A 92-year-old man with atrioventricular block had undergone Micra implantation 10 years earlier. The device battery was approaching depletion and implantation of a second LLPM was planned. Computed tomography revealed a narrow tricuspid valve and clockwise rotation of the RV. Because these anatomical features and the existing device could limit catheter maneuverability with the conventional femoral approach, the IJV approach was selected. The delivery catheter was advanced smoothly across the tricuspid valve and positioned superior to the existing device. The second Micra device was successfully deployed without mechanical interference with the initial device. No procedure-related complications occurred. The internal jugular approach may represent a useful alternative strategy for second LLPM implantation, particularly in patients with anatomical features or a previously implanted device limiting the available RV implantation site.</div></div><div><h3>Learning objective</h3><div>Implantation of a second leadless pacemaker (LLPM) may be more challenging than the initial procedure because of limited available implantation sites. LLPM implantation via the internal jugular vein (IJV) allows firm contact with the right ventricular septum and is associated with a lower risk of venous complications. The IJV approach represents a feasible alternative strategy for second Micra implantation.</div></div>","PeriodicalId":52092,"journal":{"name":"Journal of Cardiology Cases","volume":"34 5","pages":"Pages 199-202"},"PeriodicalIF":0.0,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149314826","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Histopathological insights into a swinging cardiac calcified amorphous tumor associated with mitral annular calcification: A case report","authors":"Hiroshi Tsuchiya MD, Hidehito Endo MD, Sachito Minegishi MD, Yu Takahashi MD, Yusuke Inaba MD, Hiroshi Kubota MD, PhD, FJCC","doi":"10.1016/j.jccase.2026.07.011","DOIUrl":"10.1016/j.jccase.2026.07.011","url":null,"abstract":"<div><div>Mitral annular calcification (MAC) is the most common calcific disorder of the mitral valve; however, other calcified lesions, including cardiac calcified amorphous tumor (CAT) and its highly mobile subtype, swinging CAT (S-CAT), have been reported. These entities differ markedly in their growth patterns and structural characteristics. This study aimed to clarify the mechanism underlying the development of S-CAT arising from MAC by focusing on detailed pathological findings of resected specimens, particularly along the long-axis. Histopathological analysis demonstrated that the lesion could be divided into three distinct zones, each characterized by different morphologies of calcified nodules and varying degrees of inflammatory cell infiltration. In particular, the distribution of macrophages and neutrophils differed among these regions, suggesting heterogeneity in inflammatory exposure over time. These findings indicate that localized and time-dependent inflammatory processes associated with circulating blood components may contribute to the development of S-CAT on the roughened endocardial surface overlying pre-existing MAC. Furthermore, clinical backgrounds frequently included end-stage renal disease, diabetes mellitus, obesity, and hypercholesterolemia, supporting the role of systemic metabolic and inflammatory conditions in this process. Understanding these pathological features may provide insight into the pathogenesis of S-CAT and its clinical behavior.</div></div><div><h3>Learning objective</h3><div>Previous pathological reports of swinging cardiac calcified amorphous tumor (S-CAT) have mainly focused on the distal tip of the lesion. By examining longitudinal pathological specimens from root to tip, this case demonstrates distinct regional histological differences and suggests that S-CAT develops through a chronological process involving thrombosis, inflammation, and progressive calcification arising from mitral annular calcification.</div></div>","PeriodicalId":52092,"journal":{"name":"Journal of Cardiology Cases","volume":"34 5","pages":"Pages 219-223"},"PeriodicalIF":0.0,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149314466","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Multimodality imaging features of dasatinib-induced pulmonary arterial hypertension","authors":"Chikako Awazu MD, Seitaro Oda MD, PhD, Seika Furuie MD, Ryo Shinohara MD, Hidetaka Hayashi MD, PhD, Masafumi Kidoh MD, PhD, Kyoko Hirakawa MD, PhD, Naoto Kuyama MD, PhD, Eiichiro Yamamoto MD, PhD, FJCC, Yasuhiro Izumiya MD, PhD, FJCC, Kenichi Tsujita MD, PhD, FJCC, Toshinori Hirai MD, PhD","doi":"10.1016/j.jccase.2026.07.019","DOIUrl":"10.1016/j.jccase.2026.07.019","url":null,"abstract":"<div><div>Dasatinib, a tyrosine kinase inhibitor used to treat chronic myelogenous leukemia, is associated with drug-induced pulmonary arterial hypertension (PAH). We report two cases of dasatinib-induced PAH evaluated using advanced noninvasive multimodality imaging. A comprehensive pulmonary hypertension-targeted computed tomography (CT) protocol showed no structural lung abnormalities or pulmonary embolism. However, CT pulmonary perfusion imaging revealed diffuse heterogeneous hypoperfusion in both lungs, suggesting functional pulmonary circulatory impairment. Myocardial delayed-enhancement CT demonstrated late iodine enhancement and increased extracellular volume at the right ventricular insertion points, indicating myocardial involvement related to right ventricular pressure overload. Cardiac magnetic resonance confirmed right ventricular remodeling, and right heart catheterization (RHC) established precapillary pulmonary hypertension. After discontinuation of dasatinib and initiation of pulmonary vasodilator therapy, one patient achieved partial remission and the other normalization of pulmonary hemodynamics on follow-up RHC. These findings underscore the clinical value of advanced imaging in diagnosing and characterizing drug-induced PAH.</div></div><div><h3>Learning objective</h3><div>To understand the clinical significance of noninvasive multimodality imaging, including a comprehensive pulmonary hypertension-targeted computed tomography protocol, in dasatinib-induced pulmonary arterial hypertension and to integrate imaging findings for a systematic assessment of its pathophysiology and clinical presentation.</div></div>","PeriodicalId":52092,"journal":{"name":"Journal of Cardiology Cases","volume":"34 5","pages":"Pages 231-234"},"PeriodicalIF":0.0,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149314468","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Persistent mitral regurgitation due to subvalvular fusion in hypereosinophilic syndrome despite imatinib therapy","authors":"Kensuke Oue MD, Nobuo Kondo MD, PhD, Moe Kinoshita MD","doi":"10.1016/j.jccase.2026.05.002","DOIUrl":"10.1016/j.jccase.2026.05.002","url":null,"abstract":"<div><div>Cardiac involvement is a major cause of morbidity in hypereosinophilic syndrome (HES). We report a rare case of severe mitral regurgitation (MR) associated with HES in which apparent echocardiographic regression after imatinib therapy masked irreversible structural disease. A 63-year-old man presented with progressive exertional dyspnea and heart failure caused by severe MR. Marked eosinophilia led to the diagnosis of a myeloid/lymphoid neoplasm with PDGFRB rearrangement. Transesophageal echocardiography revealed infiltrative thickening of the posterior mitral leaflet with vegetation-like subvalvular structures. Imatinib therapy rapidly normalized eosinophil counts, and follow-up echocardiography demonstrated disappearance of the vegetation-like structures; however, MR persisted. Because of progressive symptoms, mitral valve replacement was performed. Intraoperative findings revealed firm fusion of the posterior mitral leaflet and subvalvular apparatus to the left ventricular wall. The postoperative course was uneventful. This case highlights that apparent regression of valvular lesions after imatinib therapy does not necessarily indicate reversibility of structural disease in HES.</div></div><div><h3>Learning objective</h3><div>To understand that hypereosinophilic syndrome can cause irreversible subvalvular fusion leading to persistent mitral regurgitation despite adequate medical therapy, including imatinib. This case highlights the importance of careful echocardiographic evaluation of subvalvular involvement and timely consideration of surgical intervention when structural valvular damage progresses.</div></div>","PeriodicalId":52092,"journal":{"name":"Journal of Cardiology Cases","volume":"34 5","pages":"Pages 187-190"},"PeriodicalIF":0.0,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149314471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Atrial leadless pacing for heart failure in sick sinus syndrome","authors":"Shinnosuke Sato MD, Yasuyuki Takada MD, PhD, Junichi Kamoshida MD, PhD, Muryo Terasawa MD, PhD, Kazuhiro Satomi MD, PhD, Yoshinao Yazaki MD, PhD","doi":"10.1016/j.jccase.2026.07.007","DOIUrl":"10.1016/j.jccase.2026.07.007","url":null,"abstract":"<div><div>Two patients with sick sinus syndrome and heart failure were treated with atrial leadless pacing. Case 1 demonstrated hemodynamic improvement with cardiac output increase (3.0 → 5.1 L/min), B-type natriuretic peptide (BNP) reduction (3223 → 480 pg/mL), and New York Heart Association class improvement (III → I) following Aveir dual-chamber leadless pacemaker (Abbott Medical, Inc., Plymouth, MN, USA) implantation. Case 2, at high infection risk with mechanical valve and prior endocarditis, received hybrid therapy combining atrial fibrillation ablation, Aveir atrial pacing, and subcutaneous implantable cardioverter-defibrillator implantation, achieving left ventricular ejection fraction improvement (20 → 38%) and BNP reduction (321 → 28 pg/mL). Atrial leadless pacing may represent a therapeutic option in selected patients with preserved atrioventricular conduction or high infection risk requiring physiologic pacing.</div></div><div><h3>Learning objective</h3><div>This case report demonstrates that atrial leadless pacing can be an effective treatment option for patients with sick sinus syndrome complicated by heart failure when conventional transvenous atrial pacing is undesirable. In one of the presented cases, the feasibility of combining a leadless pacemaker with a subcutaneous implantable cardioverter-defibrillator is also illustrated, providing insight into a potential lead-free device strategy.</div></div>","PeriodicalId":52092,"journal":{"name":"Journal of Cardiology Cases","volume":"34 5","pages":"Pages 195-198"},"PeriodicalIF":0.0,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149314825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}